Skip to main content
. 2022 Nov 22;32(1):33–39. doi: 10.1159/000527828

Fig. 1.

Fig. 1

NF-κB/p65 protein expression in breast carcinoma cases. a Invasive ductal carcinoma grade 2 with weak NF-κB/p65 expression, ×200. b Invasive ductal carcinoma grade 2 with moderate NF-κB/p65 expression, ×200. c Invasive ductal carcinoma grade 2 with moderate NF-κB/p65 expression, ×200. d Invasive ductal carcinoma grade 2 with high NF-κB/p65 expression, ×200. e Invasive lobular carcinoma grade 2 with moderate NF-κB/p65 expression, ×400.